Cardiac Amyloidosis
Research activity is centered on transthyretin cardiac amyloidosis, with attention to the structural and functional impact of the disease on the heart. The clinical setting involves coordinated investigation in Vila Real, Portugal, within a hospital-based environment focused on patient care and research integration.
- Transthyretin cardiac amyloidosis
- Myocardial infiltration
- Cardiac dysfunction
Clinical interest includes the characterization of cardiac involvement through imaging-based assessment in patients affected by this rare cardiomyopathy.
Cardiac Magnetic Resonance Imaging
The sponsor is involved in research using cardiac magnetic resonance to examine changes in heart structure and tissue characteristics associated with amyloid disease. This area reflects a strong focus on advanced cardiovascular imaging in clinical evaluation.
- Cardiac magnetic resonance
- Myocardial tissue characterization
- Imaging biomarkers
Attention is placed on imaging parameters that help describe disease evolution and cardiac involvement over time.
Cardiology and Amyloid Heart Disease
Clinical research activity is concentrated in cardiology, particularly the management and assessment of amyloid heart disease. The sponsor’s work aligns with specialized care for patients whose cardiac symptoms are linked to protein deposition in the heart.
- Cardiology
- Amyloid cardiomyopathy
- Heart failure assessment
This includes interest in monitoring cardiac response in a disease area where imaging and clinical evaluation are closely connected.
Tafamidis-Related Clinical Interest
The sponsor supports investigation into the cardiac effects associated with tafamidis in the context of transthyretin amyloidosis. Research interest is directed toward observing how treatment relates to changes in cardiac imaging findings in affected patients.
- Tafamidis
- Transthyretin stabilization
- Treatment response
This domain links therapeutic management with imaging-based cardiac assessment in a single disease focus.
